Highlights of Ophthalmology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  52 (2024)
Volume  51 (2023)
Volume  50 (2022)
Volume  49 (2021)
Volume  48 (2020)
Volume  47 (2019)
Volume  46 (2018)
Volume  45 (2017)
Volume  44 (2016)
Volume  43 (2015)
Volume  42 (2014)
Volume  41 (2013)
Volume  40 (2012)
Volume  39 (2011)
Volume  38 (2009)
Related articles

VOLUME 44 , ISSUE 3ENG ( Jun-2016, 2016 ) > List of Articles

Proper Diagnosis for a Proper Management of Retinal Vasculitis

Samuel Boyd

Citation Information : Boyd S. Proper Diagnosis for a Proper Management of Retinal Vasculitis. 2016; 44 (3ENG):2-8.

DOI: 10.5005/highlights-44-3-2

Published Online: 29-01-2021

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Retinal vaculitis is a sight-threatening inflammatory eye condition that involves the retinal vessels. Detection of retinal vasculitis is made clinically, and confirmed with the help of fundus fluorescein angiography. Active vascular disease is characterized by exudates around retinal vessels resulting in white sheathing or cuffing of the affected vessels.

PDF Share
  1. J. T. Rosenbaum, J. Ku, A. Ali, D. Choi, and E. B. Suhler, “Patients with retinal vasculitis rarely suffer from systemic vasculitis,” Seminars in Arthritis and Rheumatism, vol. 41, no. 6, pp. 859-865, 2012.
  2. R. C. Walton and E. D. Ashmore, “Retinal vasculitis,” Current Opinion in Ophthalmology, vol. 14, no. 6, pp. 413-419, 2003.
  3. S. D. Bhaleeya and J. Davis, “Imaging retinal vascular changes in uveitis,” International Ophthalmology Clinics, vol. 52, no. 4, pp. 83-96, 2012.
  4. K. Saurabh, R. R. Das, J. Biswas, and A. Kumar, “Profile of retinal vasculitis in a tertiary eye care center in Eastern India,” Indian Journal of Ophthalmology, vol. 59, no. 4, pp. 297-301, 2011.
  5. A. M. Abu El-Asrar, C. P. Herbort, and K. F. Tabbara, “Differential diagnosis of retinal vasculitis,” Middle East African Journal of Ophthalmology, vol. 16, no. 4, pp. 202-218, 2009.
  6. J. D. Gass and C. L. Olson, “Sarcoidosis with optic nerve and retinal involvement,” Archives of Ophthalmology, vol. 94, no. 6, pp. 945-950, 1976.
  7. Rodriguez A, Calonge M, Pedroza-Seres M, et al. Referral patterns of uveitis in a tertiary eye care center. Archives of ophthalmology. May 1996;114(5):593-599.
  8. Hughes EH, Dick AD. The pathology and pathogenesis of retinal vasculitis. Neuropathology and applied neurobiology. Aug 2003;29(4):325-340.
  9. Graham EM, Stanford MR, Sanders MD, Kasp E, Dumonde DC. A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. The British journal of ophthalmology. Sep 1989;73(9):714- 721.
  10. Rothova A, Suttorp-van Schulten MS, Frits Treffers W, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. The British journal of ophthalmology. Apr 1996;80(4):332-336.
  11. Palmer HE, Stanford MR, Sanders MD, Graham EM. Visual outcome of patients with idiopathic ischaemic and non-ischaemic retinal vasculitis. Eye (London, England). 1996;10 (Pt 3):343-348.
  12. El-Asrar AM, Herbort CP, Tabbara KF. A clinical approach to the diagnosis of retinal vasculitis. International ophthalmology. Apr 2010;30(2):149-173.
  13. Abu El-Asrar AM, Herbort CP, Tabbara KF. Differential diagnosis of retinal vasculitis. Middle East African journal of ophthalmology. Oct 2009;16(4):202-218.
  14. Jennette, J. Charles. “Overview of the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.” Clinical and Experimental Nephrology 17, no. 5 (October 2013): 603-6. doi:10.1007/s10157-013-0869-6.
  15. Stanford MR, Graham EM, Kasp E, Brown EC, Dumonde DC, Sanders MD. Retinal vasculitis: correlation of animal and human disease. Eye (London, England). 1987;1 (Pt 1):69-77.
  16. Empeslidis T, Konidaris V, Brent A, Vardarinos A, Deane J. Kyrieleis plaques in herpes zoster virus-associated acute retinal necrosis: a case report. Eye (London, England). Sep 2013;27(9):1110-1112.
  17. Biswas J, Sharma T, Gopal L, Madhavan HN, Sulochana KN, Ramakrishnan S. Eales disease--an update. Survey of ophthalmology. May-Jun 2002;47(3):197-214.
  18. Graham EM, Francis DA, Sanders MD, Rudge P. Ocular inflammatory changes in established multiple sclerosis. Journal of neurology, neurosurgery, and psychiatry. Dec 1989;52(12):1360-1363.
  19. Caplan L, Corbett J, Goodwin J, Thomas C, Shenker D, Schatz N. Neuro-ophthalmologic signs in the angiitic form of neurosarcoidosis. Neurology. Sep 1983;33(9):1130-1135.
  20. Tugal-Tutkun I, Gupta V, Cunningham ET. Differential diagnosis of behcet uveitis. Ocular immunology and inflammation. Oct 2013;21(5):337-350.
  21. Iida T, Spaide RF, Kantor J. Retinal and choroidal arterial occlusion in Wegener's granulomatosis. Am J Ophthalmol. 2002;133:151-2 Ho TY, Chung YM, Lee AF, Tsai CY. Severe vaso-occlusive retinopathy as the primary manifestation in a patient with systemic lupus erythematosus. Journal of the Chinese Medical Association: JCMA. Jul 2008;71(7):377-380.
  22. Mihara M, Hayasaka S, Watanabe K, Kitagawa K, Hayasaka Y. Ocular manifestations in patients with microscopic polyangiitis. European journal of ophthalmology. Jan-Feb 2005;15(1):138-142.
  23. Kubal AA, Perez VL. Ocular manifestations of ANCA-associated vasculitis. Rheumatic diseases clinics of North America. Aug 2010;36(3):573-586.
  24. Butler NJ, Furtado JM, Winthrop KL, Smith JR. Ocular toxoplasmosis II: clinical features, pathology and management. Clinical & experimental ophthalmology. Jan- Feb 2013;41(1):95-108.
  25. Kirkwood BJ. Acute retinal necrosis. Insight (American Society of Ophthalmic Registered Nurses). Winter 2014;39(1):14-16.
  26. Roy R, Pal BP, Mathur G, Rao C, Das D, Biswas J. Acute retinal necrosis: clinical features, management and outcomes--a 10 year consecutive case series. Ocular immunology and inflammation. Jun 2014;22(3):170-174.
  27. Or C, Press N, Forooghian F. Acute retinal necrosis secondary to cytomegalovirus following successful treatment of cytomegalovirus anterior uveitis in an immunocompetent adult. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. Apr 2013;48(2):e18-20.
  28. Levy-Clarke GA, Buggage RR, Shen D, Vaughn LO, Chan CC, Davis JL. Human T-cell lymphotropic virus type-1 associated t-cell leukemia/lymphoma masquerading as necrotizing retinal vasculitis. Ophthalmology. Sep 2002;109(9):1717-1722.
  29. Chazalon E, Conrath J, Ridings B, Matonti F. [Kyrieleis arteritis: report of two cases and literature review]. Journal francais d'ophtalmologie. Mar 2013;36(3):191-196.
  30. Ito Y, Nakano M, Kyu N, Takeuchi M. Frosted branch angiitis in a child. Jpn J Clin Ophthalmol. 1976;30:797-803.
  31. Kleiner RC, Kaplan HJ, Shakin JL, Yannuzzi LA, Crosswell HH, Jr, McLean WC., Jr Acute frosted retinal periphlebitis. Am J Ophthalmol. 1988;106:27-34.
  32. Quillen DA, Stathopoulos NA, Blankenship GW, Ferriss JA. Lupus associated frosted branch periphlebitis and exudative maculopathy. Retina (Philadelphia, Pa.). 1997;17(5):449-451.
  33. Sykes SO, Horton JC. Steroid-responsive retinal vasculitis with a frosted branch appearance in Crohns disease. Retina (Philadelphia, Pa.). 1997;17(5):451-454.
  34. Oh J, Huh K, Kim SW. Recurrent secondary frosted branch angiitis after toxoplasmosis vasculitis. Acta ophthalmologica Scandinavica. Feb 2005;83(1):115-117.
  35. Leeamornsiri S, Choopong P, Tesavibul N. Frosted branch angiitis as a result of immune recovery uveitis in a patient with cytomegalovirus retinitis. Journal of ophthalmic inflammation and infection. 2013;3(1):52.
  36. Sanghvi C, Bell C, Woodhead M, Hardy C, Jones N. Presumed tuberculous uveitis: diagnosis, management, and outcome. Eye (London, England). Apr 2011;25(4):475- 480.
  37. Damato E, Chilov M, Lee R, Singh A, Harper S, Dick A. Plasma exchange and rituximab in the management of acute occlusive retinal vasculopathy secondary to systemic lupus erythematosus. Ocular immunology and inflammation. Oct 2011;19(5):379-381.
  38. Kahloun R, Mbarek S, Khairallah-Ksiaa I, Jelliti B, Yahia SB, Khairallah M. Branch retinal artery occlusion associated with posterior uveitis. Journal of ophthalmic inflammation and infection. 2013;3(1):16.
  39. Stanford MR, Verity DH. Diagnostic and therapeutic approach to patients with retinal vasculitis. International ophthalmology clinics. Spring 2000;40(2):69-83.
  40. Majumder PD, Sudharshan S, Biswas J. Laboratory support in the diagnosis of uveitis. Indian journal of ophthalmology. Jun 2013;61(6):269-276.
  41. Barry RJ, Nguyen QD, Lee RW, Murray PI, Denniston AK. Pharmacotherapy for uveitis: current management and emerging therapy. Clinical ophthalmology (Auckland, N.Z.). 2014;8:1891-1911.
  42. Saurabh K, Das RR, Biswas J, Kumar A. Profile of retinal vasculitis in a tertiary eye care center in Eastern India. Indian journal of ophthalmology. Jul-Aug 2011;59(4):297-301.
  43. Benitez Del Castillo Sanchez JM, Garcia Sanchez J. [Intravitreal injection of triamcinolone acetonide in non infectious uveitis]. Archivos de la Sociedad Espanola de Oftalmologia. Nov 2001;76(11):661-664.
  44. Kok H, Lau C, Maycock N, McCluskey P, Lightman S. Outcome of intravitreal triamcinolone in uveitis. Ophthalmology. Nov 2005;112(11):1916.e1911-1917.
  45. Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. American journal of ophthalmology. Oct 2000;130(4):492-513.
  46. Comarmond C, Wechsler B, Cacoub P, Saadoun D. Approaches to immunosuppression in Behcet's disease. Immunotherapy. Jul 2013;5(7):743-754.
  47. Whitcup SM, Salvo EC, Jr., Nussenblatt RB. Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behcet's disease. American journal of ophthalmology. Jul 15 1994;118(1):39-45.
  48. Ozdal PC, Ortac S, Taskintuna I, Firat E. Long-term therapy with low dose cyclosporin A in ocular Behcet's disease. Documenta ophthalmologica. Advances in ophthalmology. Nov 2002;105(3):301-312.
  49. Greenwood AJ, Stanford MR, Graham EM. The role of azathioprine in the management of retinal vasculitis. Eye (London, England). 1998;12 (Pt 5):783-788.
  50. Palmares J, Castro-Correia J, Coutinho MF, Araujo D, Delgado L. Immunosuppression in Behcet's disease Clinical management and long-term visual outcome. Ocular immunology and inflammation. 1995;3(2):99-106.
  51. Davatchi F, Sadeghi Abdollahi B, Shams H, et al. Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years. International journal of rheumatic diseases. May 2014;17(4):444-452.
  52. Pasadhika S, Rosenbaum JT. Update on the use of systemic biologic agents in the treatment of noninfectious uveitis. Biologics: targets & therapy. 2014;8:67-81.
  53. Okinami S, Sunakawa M, Arai I, Iwaki M, Nihira M, Ogino N. Treatment of pars planitis with cryotherapy. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde. 1991;202(4):180-186.
  54. Davatchi F, Nikbin B, Shams H, Sadeghi Abdollahi B, Mohyeddin M, Shahram F. Mesenchymal stem cell therapy unable to rescue the vision from advanced Behcet's disease retinal vasculitis: report of three patients. International journal of rheumatic diseases. Apr 2013;16(2):139-147.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.